共 50 条
- [1] Estimation of serum "true collagen type III formation" (Pro-C3) levels as a marker of non-alcoholic steatohepatitis in a prospective cohortJOURNAL OF HEPATOLOGY, 2017, 66 (01) : S154 - S154Leeming, D. J.Grove, J. I.Kaye, P.Hoad, C.Francis, S.Nielsen, M. J.Karsdal, M. A.Guha, I. N.Aithal, G. P.
- [2] Pro-C3 in combination with clinical parameters is associated with severity of histological features of non-alcoholic steatohepatitis and fibrosisHEPATOLOGY, 2017, 66 : 1107A - 1108ALeeming, Diana J.Nielsen, Mette J.Goodman, Zachary D.Friedman, Scott L.Lefebvre, EricSeyedka-Zemi, StarWiens, BrianFischer, LaurentKarsdal, Morten A.Sanyal, Arun J.Ratziu, Vlad
- [3] Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseJHEP REPORTS, 2019, 1 (03) : 188 - 198Boyle, MarieTiniakos, DinaSchattenberg, Jorn M.Ratziu, VladBugianessi, ElisabettaPetta, SalvatoreOliveira, Claudia P.Govaere, OlivierYounes, RamyMcPherson, StuartBedossa, PierreNielsen, Mette J.Karsdal, MortenLeeming, DianaKendrick, StuartAnstee, Quentin M.
- [5] A simple biomarker panel predictive of advanced fibrosis in patients with non-alcoholic steatohepatitisJOURNAL OF HEPATOLOGY, 2019, 70 (01) : E787 - E787Younossi, ZobairKarrar, AzzaStepanova, MariaLam, BrianFelix, SeanJeffers, ThomasHellings, SamuelBrown, ElizabethSpires, ThomasYarde, MelissaLuo, YiSanfiz, AnthonyZhelnin, LeonidJarai, GaborCvijic, Mary EllenCharles, EdgarMukherjee, SumantaZhao, LeiGordon, DavidNader, FatemaGoodman, Zachary
- [6] BMS-986036, a PEGylated fibroblast growth factor 21 analogue, reduces fibrosis and Pro-C3 in a mouse model of non-alcoholic steatohepatitisJOURNAL OF HEPATOLOGY, 2018, 68 : S396 - S397Luo, Y.Krupinski, J.Gao, S.Charles, E.Christian, R.
- [7] ASSOCIATIONS OF ENHANCED LIVER FIBROSIS (ELF) AND PRO-C3 WITH STAGE OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)HEPATOLOGY, 2021, 74 : 803A - 804AFelix, SeanLam, Brian P.Jeffers, ThomasGoodman, Zachary D.Stepanova, MariaYounossi, Zobair M.
- [8] Reduction in types I and III collagen gene expression by an alphavbeta1 integrin inhibitor correlates with a decrease in PRO-C1 and PRO-C3 levels in precision-cut liver tissue slices from cirrhotic non-alcoholic steatohepatitis patientsJOURNAL OF HEPATOLOGY, 2020, 73 : S517 - S518Schaub, JohannaHo, SteveRao, VikramMarlow, MeganLefebvre, EricLeeming, DianaNielsen, Mette JuulGudmann, NatasjaKarsdal, MortenTurner, Scott
- [9] N-terminal propeptide of type III collagen (PRO-C3) based risk for liver fibrosis predict cardiovascular events in non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY, 2022, 77 : S161 - S161Baratta, FrancescoTozzi, GiuliaPastori, DanieleColantoni, AlessandraCocomello, NicholasCecchi, StefanoCoronati, MattiaAngelico, FrancescoDel Ben, Maria
- [10] PROTEIN PATHWAY BIOMARKER SIGNATURE ASSOCIATED WITH SUPERIMPOSED NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS CJOURNAL OF HEPATOLOGY, 2010, 52 : S157 - S157Stepanova, M.Limongi, D.Afendy, A.Pierobon, M.Younossi, I.Gramlich, T.Liotta, L.Petricoin, E.Younossi, Z.